ABAndreas Boss

Andreas Boss

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andreas Boss has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The IVIM signal in the healthy cerebral gray matter: A play of spherical and non-spherical components

    by Tim Finkenstaedt, Markus Klarhoefer, Christian Eberhardt, Anton S. Becker, Gustav Andreisek, Andreas Boss, Cristina Rossi


  • Measurement of glomerular filtration rate using dynamic magnetic resonance imaging in patients with chronic kidney disease

    by Ferruh Artunc, Serdar Yildiz, Andreas Boss, Thomas Frenzel, Heinz-Peter Schlemmer, Fritz Schick, Teut Risler, Hans-Ulrich Häring, Cristina Rossi

    Determination of glomerular filtration rate (GFR) using plasma disappearance curves requires the injection of a filtration marker and repeated timed blood collections. Gadolinium-containing contrast media are excreted exclusively by glomerular filtration and could provide a novel approach to quantifying GFR using magnetic resonance (MR) imaging. The aim of this study was to demonstrate the feasibility of measuring GFR by the clearance of gadolinium-containing contrast medium in patients with chronic kidney disease (CKD). Informed consent was obtained from stable CKD patients in stages 1, 2 or 3 (n=16; 5 women, 11 men; median age 54 years). GFR was measured after a bolus injection of gadobutrol (4 mL, approximately 0.05 mmol/kg) and calculated from the washout of the signal intensity obtained over the liver. The obtained MR-GFR was compared with simultaneously measured plasma clearance of inulin and gadobutrol. Technical failure occurred in 2 patients. The mean obtained MR-GFR was 71 ± 25 (SD) mL/min per 1.73 m² and agreed well with the mean inulin-GFR (70 ± 24 mL/min per 1.73 m²). Pearson's correlation coefficient was r=0.91. The mean of the paired differences was 1 ± 10 mL/min per 1.73 m² and not significantly different from zero. GFR obtained from gadobutrol plasma clearance also agreed well with inulin-GFR and MR-GFR (r=0.92 and r=0.75, respectively). We describe a novel method of determining GFR from MR imaging using a low dose of gadobutrol in patients with reduced GFR that enables the absolute quantification of GFR after routine contrast-enhanced MR imaging.


  • Minimal-invasive Therapie des Nierenkrebs: die perkutane Radiofrequenzablation

    by Andreas Boss, Philippe L Pereira

    In den letzten Jahren wird ein Anstieg der Inzidenz des Nierenzellkarzinoms verzeichnet, der vorwiegend auf die zunehmende Anzahl zufällig entdeckter kleiner Tumoren zurückzuführen ist. Die perkutane Radiofrequenzablation (RFA) ist ein minimal-invasives thermoablatives Verfahren zur Tumortherapie, das besonders zur Therapie kleiner renaler Tumoren geeignet ist. Als minimal-invasive Methode bietet die RFA eine geringere Patientenmorbidität und eine Reduktion der Kosten im Gesundheitswesen durch verkürzte Krankenhausaufenthalte. Bei der RFA werden ein bis drei RF-Applikatoren im Tumor platziert, durch das Anliegen eines Hochfrequenz-Wellenfeldes wird thermale Energie in diesen Tumor eingebracht. Es kommt zur irreversiblen thermischen Zerstörung der Tumorzellen. In zahlreichen Studien konnte gezeigt werden, dass die RFA ein sicheres und effektives Verfahren zur lokalen Destruktion von Nierenzellkarzinomen kleiner 5 cm darstellt. The incidence of renal cell carcinoma is rising with an incidence of 150,000 cases per anno. Diagnosis of renal cell carcinoma is made earlier mostly because of incidental diagnostic during ultrasound, computer- or magnet-resonance tomography. Further, renal cell carcinoma often occurs in advanced age, with patients being poor candidates for surgical resection or even nephrectomy. During the past few years, percutaneous imaging-guided radiofrequency ablation has evolved as a minimally-invasive treatment alternative of small renal tumours offering not only reduced patient morbidity but also overall health-care costs. During radiofrequency ablation, thermal energy is applicated into tumor tissue by means of a needle-like applicator just under local anesthesia. Some patients can be even ambulatory treated on out-patient basis. In several recent studies and in metaanalysis, percutaneous radiofrequency ablation has been shown to be an effective and safe modality for local destruction of renal cell carcinoma up to 5 cm. Overall complication rates are lower compared with partial or total nephrectomy. Altogether, radiofrequency ablation is a new modality for the minimally-invasive treatment of renal cell carcinoma, which was demonstrated to exhibit high term effectiveness.

  • Open Access

    Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT

    by Andreas Boss, Sotirios Bisdas, Armin Kolb, Matthias Hofmann, Ulrike Ernemann, Claus D. Claussen, Christina Pfannenberg, Bernd J. Pichler, Matthias Reimold, Lars Stegger

    Simultaneous PET and MRI using new hybrid PET/MRI systems promises optimal spatial and temporal coregistration of structural, functional, and molecular image data. In a pilot study of 10 patients with intracranial masses, the feasibility of tumor assessment using a PET/MRI system comprising lutetium oxyorthosilicate scintillators coupled to avalanche photodiodes was evaluated, and quantification accuracy was compared with conventional PET/CT datasets. Methods: All measurements were performed with a hybrid PET/MRI scanner consisting of a conventional 3-T MRI scanner in combination with an inserted MRI-compatible PET system. Attenuation correction of PET/MR images was computed from MRI datasets. Diagnoses at the time of referral were low-grade astrocytoma (n = 2), suspicion of low-grade astrocytoma (n = 1), anaplastic astrocytoma (World Health Organization grade III; n = 1), glioblastoma (n = 2), atypical neurocytoma (n = 1), and meningioma (n = 3). In the glial tumors, 11C-methionine was used for PET; in the meningiomas, 68Ga-DOTATOC was administered. Tumor–to–gray matter and tumor–to–white matter ratios were calculated for gliomas, and tracer uptake of meningiomas was referenced to nasal mucosa. PET/MRI was performed directly after clinically indicated PET/CT examination. Results: In all patients, the PET datasets showed similar diagnostic image quality on the hybrid PET/MRI and the PET/CT studies; however, slight streak artifacts were visible in coronal and sagittal sections when using the higher intrinsic resolution of the PET/MRI insert. Prefiltering of images with a 4-mm gaussian filter at a resolution comparable to that of the PET/CT system virtually eliminated these artifacts. Although acquisition of the PET/MR images started at 30–60 min after PET/CT (20.4-min half-life of 11C) acquisition, the signal-to-noise ratio was good enough, thus underlining the high sensitivity of the PET insert, compared with whole-body PET systems. The computed tumor–to–reference tissue ratios exhibited an excellent accordance between the PET/MRI and PET/CT systems, with a Pearson correlation coefficient of 0.98. Mean paired relative error was 7.9% ± 12.2%. No significant artifacts or distortions were detected in the simultaneously acquired MR images using the PET/MRI scanner. Conclusion: Structural, functional, and molecular imaging in patients with brain tumors is feasible with diagnostic imaging quality using simultaneous hybrid PET/MR image acquisition.


  • Diffusion Tensor Imaging in a Human PET/MR Hybrid System

    by Andreas Boss, Armin Msc Kolb, Matthias Msc Hofmann, Sotirios Bisdas, Thomas Nägele, Ulrike Ernemann, Lars Stegger, Cristina Rossi, Heinz-Peter Schlemmer, Christina Pfannenberg, et al.

    Purpose: The aim of this study was to test and demonstrate the feasibility of diffusion tensor imaging (DTI) with a hybrid positron emission tomography (PET)/magnetic resonance imaging system for simultaneous PET and magnetic resonance (MR) data acquisition. Materials and Methods: All measurements were performed with a prototype hybrid PET/MR scanner dedicated for brain and head imaging. The PET scanner, which is inserted into a conventional 3.0-Tesla high field MR imager equipped with a transmit/receive birdcage head coil, consists of 192 block detectors with a matrix of 12 × 12 lutetium oxyorthosilicate scintillation crystals combined with MR-compatible 3 × 3 avalanche photodiode arrays. In 7 volunteers and 4 patients with brain tumors, DTI was performed during simultaneous PET data readout applying a diffusion weighted echo planar sequence (12 noncollinear directions, echo time (TE)/repetition time (TR) 98 ms/5300 ms, b-value 800 s/mm2). Image quality and accuracy of DTI were assessed in comparison with DTI images acquired after removal of the PET insert. Results: The diffusion images showed good image quality in all volunteers regardless of simultaneous PET data readout or after removal of the PET scanner; however, significantly (P < 0.01) stronger rim artifacts were found in fractional anisotropy images computed from DTI images recorded during simultaneous PET acquisition, demonstrating higher eddy-current effects. In region of interest analysis, no notable differences were found in the computation of the direction of the principal eigenvector (P > 0.05) and fractional anisotropy values (P > 0.05). In the assessment of pathologies, in all 4 patients PET and DTI provided important clinical information in addition to conventional magnetic resonance imaging. Conclusion: Diffusion tensor imaging may be combined with simultaneous PET data acquisition, offering additional important morphologic and functional information for treatment planning in patients with brain tumors.


  • Hybride PET/MRT-Bildgebung von intracraniellen Tumoren: Erste Erfahrungen und Vergleich zum PET/CT

    by A Boss, S Bisdas, A Kolb, M Hofmann, T Nägele, U Ernemann, Hp Schlemmer, C Claussen, M Reimold, C Pfannenberg, et al.

    Ziele: In einer Pilotstudie von 8 Patienten mit intracraniellen Tumoren wurden simultane Positronen-Emissions-Tomographien (PET) und Magnetresonanz-Tomographien (MRT) an einem hybriden PET/MRT-Scanner durchgeführt. Wir berichten über unsere ersten Erfahrungen und einen Vergleich zur PET/Computer-Tomographie (CT). Methode: Acht Patienten mit intracraniellen Tumoren wurden an einem hybriden PET/MRT-Scanner untersucht, welcher aus einem konventionellen 3T MR-Tomographen (Siemens Tim Trio) und einem eingeschobenen MR-kompatiblen PET-System (Siemens BrainPET) besteht. Vor der PET/MRT wurde bei allen Patienten eine PET/CT-Untersuchung an einem Siemens Hi-Rez Biograph 16 durchgeführt. Die Diagnosen waren: 1x V.a. niedriggradiges Astrozytom, 2x Astrozytom WHO-Grad II, 2x Glioblastom, 1x Neurozytom und 2x Meningeom. Bei den glialen Tumoren wurde [11C]-Methionin als Tracer appliziert, bei den beiden Meningeomen [68Ga]-DOTA-D-Phe1-Tyr3-octreotide (DOTA-TOC). Tumor-zu-Graue-Substanz-Werte wurden für die Gliome berechnet, bei den Meningeomen wurde das Verhältnis von Tumor zu Nasenschleimhaut gebildet. Ergebnis: Bei allen Patienten zeigten die PET-Datensätze sowohl bei der hybriden PET/MRT-Bildgebung als auch bei der PET/CT eine diagnostische Bildqualität. In den koronaren und sagittalen Reformationen reduzierten leichte Streifenartefakte geringfügig die Bildqualität des PET-Datensatzes. Die Tumor-zu-Referenzgewebe-Verhältnisse zeigten eine hohe Übereinstimmung zwischen den beiden Modalitäten mit einem Korrelationskoeffizienten von 0,96. Die mittlere gepaarte Abweichung betrug 14,7+-11,7%. In den simultan akquirierten MRT-Datensätzen waren keine signifikanten Artefakte oder Verzerrungen nachweisbar. Schlussfolgerung: Die „Hot Spot“ Bildgebung bei Patienten mit Gehirntumoren ist in diagnostischer Bildqualität an einem Scanner mit simultaner PET/MRT-Bildakquisition durchführbar. Das Rekonstruktionsverfahren ist unter ständiger Weiterentwicklung, so dass mit einer weiteren Reduzierung der Streifenartefakte gerechnet werden kann. Korrespondierender Autor: Boss A Universität Tübingen, Abteilung für diagnostische und interventionelle Radiologie, Hoppe-Seyler-Str 3, 72076 Tübingen E-Mail: andreas.boss@med.uni-tuebingen.de

  • Magnetic resonance spin-labeling perfusion imaging of synovitis in inflammatory arthritis at 3.0 T

    by Andreas Boss, Petros Martirosian, Jan Fritz, Ina Kötter, Jörg C. Henes, Claus D. Claussen, Fritz Schick, Marius Horger


  • Open Access

    Measurement of T1, T2, and magnetization transfer properties during embryonic development at 7 Tesla using the chicken model

    by Andreas Boss, Matthias Oppitz, Hans F. Wehrl, Cristina Rossi, Markus Feuerstein, Claus D. Claussen, Ulrich Drews, Bernd J. Pichler, Fritz Schick

    Purpose To evaluate whether techniques of high field magnetic resonance imaging may be used to characterize embryonic tissue during proliferation and differentiation. Materials and Methods Thirteen chicken embryos with incubation times between 5 days and 16 days have been measured in a small animal magnetic resonance imager (ClinScan, Bruker) at 7 Tesla using the built-in resonator. T1, T2-, and magnetization transfer imaging was performed using fast spin-echo with inversion recovery, half acquisition single shot turbo spin-echo, and spoiled gradient-echo sequences with and without off-resonance pulse, respectively. T1, T2, and magnetization transfer ratio (MTR) maps were calculated on a pixel-by-pixel basis. Results T1-, T2-, and MTR maps showed good image quality allowing for delineation of embryonic organs. During embryonic development, a decrease of T1 and T2 relaxation times was found, whereas, embryonic tissue typically showed an increase of magnetization transfer, for example, liver properties at day 5: T1 = 2431 ± 163 ms, T2 = 122 ± 12 ms, MTR = 9.2 ± 4.2%; liver properties at day 16: T1 = 1763 ± 89 ms, T2 = 71 ± 4 ms, MTR = 16.9 ± 2.2%. Conclusion Embryonic tissues show changing relaxation and magnetization transfer properties during development, therefore, high field MRI seems suitable for characterization of tissue replacement derived from embryonic stem cells. J. Magn. Reson. Imaging 2008;28:1510–1514.


  • Magnetic Resonance Imaging of Lung Tissue: Influence of Body Positioning, Breathing and Oxygen Inhalation on Signal Decay Using Multi-Echo Gradient-Echo Sequences

    by Andreas Boss, Susanne Schaefer, Petros Martirosian, Claus D. Claussen, Fritz Schick, Juergen F. Schaefer

    To assess susceptibility related signal decay in lung tissue and to measure the influence of body positioning, together with inspiration and expiration, as well as oxygen inhalation. T2* maps and line shape maps of lung parenchyma were derived from datasets acquired at 0.2 T and compared with findings at 1.5 T. The line shape maps allow for a visualization of the intravoxel frequency distribution of lung parenchyma. A multiecho spoiled gradient-echo sequence with 16 echoes was implemented both on a 0.2 T [repetition time (TR) = 100 milliseconds, echo time (TE)1 = 2.15 milliseconds, ΔTE = 2.94 milliseconds, flip angle 30 degrees] and on a 1.5 T magnetic resonance scanner (TR = 100 milliseconds, TE1 = 1.25 milliseconds, ΔTE = 1.65 milliseconds, flip angle 30 degrees). Sagittal datasets were recorded in 8 healthy volunteers at 0.2 T in supine position under maximal expiration and inspiration and during oxygen breathing. Additional measurements were performed after 20 minutes inside the scanner in supine position and after prone repositioning. In 2 volunteers, further datasets were acquired at 1.5 T. Color-encoded T2* maps and full-width-at-half-maximum (FWHM) maps of the frequency distribution were computed on a pixel-by-pixel basis. T2* maps were generated by mono-exponential fitting and, additionally, with an extended nonexponential fitting approach. The FWHM maps were calculated with a model-free approach using a discrete Fast Fourier Transformation. A notably slower T2* decay was found at 0.2 T (T2*: 5.9–11.8 milliseconds) when compared with 1.5 T (T2*: 1.0–1.4 milliseconds), allowing for the measurement of up to 6 to 8 gradient echoes above the noise level. The T2* maps and the FWHM maps computed from the datasets acquired at 0.2 T allowed regional comparison of the derived parameters. If volunteers were positioned in supine position, expiration resulted in a T2* of 10.9 ± 1.0 milliseconds and a FWHM of 47.1 ± 4.0 Hz in the dorsal lung. Significant changes (P < 0.05) were found, eg, in the ventral lung in expiration (T2*: 7.5 ± 0.8, FWHM: 76.7 ± 11.2) versus dorsal lung in expiration, in the dorsal lung in inspiration (T2*: 8.4 ± 1.0, FWHM: 67.8 ± 12.5) versus dorsal lung in expiration, in the dorsal lung during oxygen breathing (T2*: 8.7 ± 1.1, FWHM: 52.2 ± 5.2) versus dorsal lung while breathing room air, and in the dorsal lung in prone position (T2*: 8.5 ± 0.6, FWHM: 67.0 ± 9.2) versus dorsal lung in supine position. The proposed method allows for the computation of color-encoded T2* maps and FWHM maps of lung parenchyma in good image quality using datasets acquired at 0.2 T. The technique is robust and sensitive to physiological changes of lung magnetic resonance properties, eg, due to the type of body positioning or oxygen breathing.


  • Biopsy needle tips with markers—MR compatible needles for high‐precision needle tip positioning

    by Bernd M. Müller‐Bierl, Petros Martirosian, Hansjörg Graf, Andreas Boss, Claudius König, Philippe L. Pereira, Fritz Schick

    Needle tip visualization is of high importance in magnetic resonance imaging (MRI) guided interventional procedures, for example for taking biopsies from suspicious lesions in the liver or kidney. The exact position of the needle tip is often obscured by image artifacts arising from the magnetic properties of the needle. The authors investigated two special biopsy needle tip designs using diamagnetic coatings. For common interventional MR sequences, the needle tip can be identified in the MR image by several equidistant dark spots arranged along a straight line. A dotted instead of a solid line allows for an improved control of the movement of the needle, not only if the needle is tilted toward the imaging plane, but also if the needle leaves an empty canal with signal extinction, which cannot be distinguished from the needle material itself. With the proposed design the position of the needle tip can be estimated with a precision of approximately 1 mm using conventional FLASH, FISP, and TSE sequences, as used for interventional MR. Furthermore, the size of the biopsy probe can be estimated from the artifact. In using needles with a properly designed tip coating, taking biopsies under MR control is beginning to be greatly simplified. The approach to design artifacts using diamagnetic material in combination with paramagnetic material paves the way toward new instruments and implants, suitably tailored to the needs of the interventional radiologist.